{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:40:59Z","timestamp":1791405659334,"version":"4.3.3"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"11","funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Immunai"},{"DOI":"10.13039\/100005348","name":"American Association for Thoracic Surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Immunotherapies have shown great promise in pleural mesothelioma (PM), yet most patients still do not achieve significant clinical response, highlighting the importance of improving the understanding of the tumor microenvironment (TME). Here, we utilized high-throughput, single-cell RNA sequencing (scRNA-seq) to de novo identify 54 expression programs and construct a comprehensive cellular catalog of the PM TME. We found four cancer-intrinsic programs associated with poor disease outcome and a novel fetal-like, endothelial cell population that likely responds to VEGF signaling and promotes angiogenesis. Across cellular compartments, we observe substantial difference in the TME associated with a cancer-intrinsic sarcomatoid signature, including enrichment in fetal-like endothelial cells, CXCL9+ macrophages, and cytotoxic, exhausted, and regulatory T cells, which we validated using imaging and bulk deconvolution analyses on independent cohorts. Finally, we show, both computationally and experimentally, that NKG2A:HLA-E interaction between NK and tumor cells represents an important new therapeutic axis in PM, especially for epithelioid cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This manuscript presents the first single-cell RNA sequencing atlas of PM tumor microenvironment. Findings of translational relevance, validated experimentally and using independent bulk cohorts, include identification of gene programs predictive of survival, a fetal-like endothelial cell population, and NKG2A blockade as a promising new immunotherapeutic intervention in PM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-23-0017","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T15:45:01Z","timestamp":1720021501000},"page":"2262-2278","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma"],"prefix":"10.1158","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8102-5266","authenticated-orcid":false,"given":"Bruno","family":"Giotti","sequence":"first","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6983-0052","authenticated-orcid":false,"given":"Komal","family":"Dolasia","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-1419","authenticated-orcid":false,"given":"William","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4774-4392","authenticated-orcid":false,"given":"Peiwen","family":"Cai","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4781-3685","authenticated-orcid":false,"given":"Robert","family":"Sweeney","sequence":"additional","affiliation":[{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4091-8193","authenticated-orcid":false,"given":"Elliot","family":"Merritt","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3979-4032","authenticated-orcid":false,"given":"Evgeny","family":"Kiner","sequence":"additional","affiliation":[{"name":"4Immunai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-336X","authenticated-orcid":false,"given":"Grace S.","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7311-0283","authenticated-orcid":false,"given":"Atharva","family":"Bhagwat","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4875-1930","authenticated-orcid":false,"given":"Thinh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6319-0372","authenticated-orcid":false,"given":"Samarth","family":"Hegde","sequence":"additional","affiliation":[{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5566-5953","authenticated-orcid":false,"given":"Bailey G.","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"7Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-0322","authenticated-orcid":false,"given":"Sanjana","family":"Shroff","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-793X","authenticated-orcid":false,"given":"Travis","family":"Dawson","sequence":"additional","affiliation":[{"name":"5The Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3356-4008","authenticated-orcid":false,"given":"Monica","family":"Garcia-Barros","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6575-8870","authenticated-orcid":false,"given":"Jamshid","family":"Abdul-Ghafar","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0021-2561","authenticated-orcid":false,"given":"Rachel","family":"Chen","sequence":"additional","affiliation":[{"name":"5The Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-9520","authenticated-orcid":false,"given":"Sacha","family":"Gnjatic","sequence":"additional","affiliation":[{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9108-7364","authenticated-orcid":false,"given":"Alan","family":"Soto","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9280-517X","authenticated-orcid":false,"given":"Rachel","family":"Brody","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0192-4400","authenticated-orcid":false,"given":"Seunghee","family":"Kim-Schulze","sequence":"additional","affiliation":[{"name":"5The Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7403-7015","authenticated-orcid":false,"given":"Zhihong","family":"Chen","sequence":"additional","affiliation":[{"name":"5The Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3075-9977","authenticated-orcid":false,"given":"Kristin G.","family":"Beaumont","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-7827","authenticated-orcid":false,"given":"Miriam","family":"Merad","sequence":"additional","affiliation":[{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7718-7422","authenticated-orcid":false,"given":"Raja M.","family":"Flores","sequence":"additional","affiliation":[{"name":"8Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9267-2426","authenticated-orcid":false,"given":"Robert P.","family":"Sebra","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-2810","authenticated-orcid":false,"given":"Amir","family":"Horowitz","sequence":"additional","affiliation":[{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-8191","authenticated-orcid":false,"given":"Thomas U.","family":"Marron","sequence":"additional","affiliation":[{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3327-0811","authenticated-orcid":false,"given":"Anna","family":"Tocheva","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-2917","authenticated-orcid":false,"given":"Andrea","family":"Wolf","sequence":"additional","affiliation":[{"name":"3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"8Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-4414","authenticated-orcid":false,"given":"Alexander M.","family":"Tsankov","sequence":"additional","affiliation":[{"name":"1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"2Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York."},{"name":"3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"2026041310015943800_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM196503182721104","article-title":"Relation between exposure to asbestos and mesothelioma","volume":"272","author":"Selikoff","year":"1965","journal-title":"N Engl J Med"},{"key":"2026041310015943800_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","article-title":"Global incidence, risk factors, and temporal trends of mesothelioma: a population-based study","volume":"18","author":"Huang","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2026041310015943800_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s42003-018-0180-x","article-title":"Mesothelial to mesenchyme transition as a major developmental and pathological player in trunk organs and their cavities","volume":"1","author":"Koopmans","year":"2018","journal-title":"Commun Biol"},{"key":"2026041310015943800_bib4","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"2026041310015943800_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"2026041310015943800_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"2026041310015943800_bib7","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1016\/j.jtho.2018.08.277","article-title":"OA08.03 phase II trial of pembrolizumab (NCT02399371) in previously-treated malignant mesothelioma (MM): final analysis","volume":"13","author":"Desai","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2026041310015943800_bib8","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"2026041310015943800_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"2026041310015943800_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41588-023-01321-1","article-title":"Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity","volume":"55","author":"Mangiante","year":"2023","journal-title":"Nat Genet"},{"key":"2026041310015943800_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ebiom.2019.09.003","article-title":"Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions","volume":"48","author":"Alcala","year":"2019","journal-title":"EBioMedicine"},{"key":"2026041310015943800_bib12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41467-019-09307-6","article-title":"Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications","volume":"10","author":"Blum","year":"2019","journal-title":"Nat Commun"},{"key":"2026041310015943800_bib13","doi-asserted-by":"crossref","first-page":"e98575","DOI":"10.1172\/jci.insight.98575","article-title":"Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma","volume":"3","author":"Lee","year":"2018","journal-title":"JCI Insight"},{"key":"2026041310015943800_bib14","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/2159-8290.CD-20-1376","article-title":"Decoding cancer biology one cell at a time","volume":"11","author":"Gonzalez Castro","year":"2021","journal-title":"Cancer Discov"},{"key":"2026041310015943800_bib15","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1002\/cam4.5915","article-title":"Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: a review of the National Cancer Database","volume":"12","author":"Bou-Samra","year":"2023","journal-title":"Cancer Med"},{"key":"2026041310015943800_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-22-0681","article-title":"A novel irreversible TEAD inhibitor, SWTX-143, blocks hippo pathway transcriptional output and causes tumor regression in preclinical mesothelioma models","volume":"23","author":"Hillen","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"2026041310015943800_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ng0893-415","article-title":"The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma","volume":"4","author":"Park","year":"1993","journal-title":"Nat Genet"},{"key":"2026041310015943800_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-017-0732-6","article-title":"Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression","volume":"16","author":"Yang","year":"2017","journal-title":"Mol Cancer"},{"key":"2026041310015943800_bib19","doi-asserted-by":"crossref","first-page":"113673","DOI":"10.18632\/oncotarget.22817","article-title":"Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma","volume":"8","author":"Hylebos","year":"2017","journal-title":"Oncotarget"},{"key":"2026041310015943800_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/antiox11020275","article-title":"The crosstalk between GPR81\/IGFBP6 promotes breast cancer progression by modulating lactate metabolism and oxidative stress","volume":"11","author":"Longhitano","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"2026041310015943800_bib21","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1038\/s41388-019-0785-7","article-title":"ROR1-CAVIN3 interaction required for caveolae-dependent endocytosis and pro-survival signaling in lung adenocarcinoma","volume":"38","author":"Yamaguchi","year":"2019","journal-title":"Oncogene"},{"key":"2026041310015943800_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41586-020-2922-4","article-title":"A molecular cell atlas of the human lung from single-cell RNA sequencing","volume":"587","author":"Travaglini","year":"2020","journal-title":"Nature"},{"key":"2026041310015943800_bib23","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1016\/j.cell.2022.11.005","article-title":"A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates","volume":"185","author":"He","year":"2022","journal-title":"Cell"},{"key":"2026041310015943800_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2020.08.040","article-title":"Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma","volume":"183","author":"Sharma","year":"2020","journal-title":"Cell"},{"key":"2026041310015943800_bib25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2009-03-211391","article-title":"Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis","volume":"114","author":"Wei","year":"2009","journal-title":"Blood"},{"key":"2026041310015943800_bib26","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1242\/dev.125.22.4565","article-title":"Requirement of the MADS-box transcription factor MEF2C for vascular development","volume":"125","author":"Lin","year":"1998","journal-title":"Development"},{"key":"2026041310015943800_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.0.CO;2-F","article-title":"ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3","volume":"178","author":"Oda","year":"1999","journal-title":"J Cell Physiol"},{"key":"2026041310015943800_bib28","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","article-title":"VISTA is an immune checkpoint molecule for human T cells","volume":"74","author":"Lines","year":"2014","journal-title":"Cancer Res"},{"key":"2026041310015943800_bib29","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.4049\/jimmunol.0803340","article-title":"IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer","volume":"182","author":"Andersson","year":"2009","journal-title":"J Immunol"},{"key":"2026041310015943800_bib30","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res"},{"key":"2026041310015943800_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2016.08.013","article-title":"IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively","volume":"45","author":"Sichien","year":"2016","journal-title":"Immunity"},{"key":"2026041310015943800_bib32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.159.2.794","article-title":"Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages","volume":"159","author":"Lehtonen","year":"1997","journal-title":"J Immunol"},{"key":"2026041310015943800_bib33","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.3390\/cancers13246167","article-title":"Effector mechanisms of CD8+ HLA-DR+ T cells in breast cancer patients who respond to neoadjuvant chemotherapy","volume":"13","author":"Osuna-G\u00f3mez","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026041310015943800_bib34","doi-asserted-by":"crossref","first-page":"eabj1249","DOI":"10.1126\/sciadv.abj1249","article-title":"Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells","volume":"7","author":"Horiuchi","year":"2021","journal-title":"Sci Adv"},{"key":"2026041310015943800_bib35","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.3390\/ijms23105786","article-title":"Epithelioid pleural mesothelioma is characterized by tertiary lymphoid structures in long survivors: results from the MATCH study","volume":"23","author":"Mannarino","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026041310015943800_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","article-title":"Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer","volume":"3","author":"Liu","year":"2022","journal-title":"Nat Cancer"},{"key":"2026041310015943800_bib37","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"2026041310015943800_bib38","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gr.273300.120","article-title":"A single-cell tumor immune atlas for precision oncology","volume":"31","author":"Nieto","year":"2021","journal-title":"Genome Res"},{"key":"2026041310015943800_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"2026041310015943800_bib40","doi-asserted-by":"crossref","first-page":"102017","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin) in cancer treatment: a review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"2026041310015943800_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2020.09.022","article-title":"Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort","volume":"150","author":"Chia","year":"2020","journal-title":"Lung Cancer"},{"key":"2026041310015943800_bib42","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41590-022-01253-8","article-title":"Targeting TFH cells in human diseases and vaccination: rationale and practice","volume":"23","author":"Yu","year":"2022","journal-title":"Nat Immunol"},{"key":"2026041310015943800_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2026041310015943800_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-023-01816-9","article-title":"Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy","volume":"22","author":"Torricelli","year":"2023","journal-title":"Mol Cancer"},{"key":"2026041310015943800_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/d41573-020-00166-1","article-title":"Immuno-oncology drug development forges on despite COVID-19","volume":"19","author":"Upadhaya","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"2026041310015943800_bib46","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/ijc.32363","article-title":"NK- and T-cell subsets in malignant mesothelioma patients: baseline pattern and changes in the context of anti-CTLA-4 therapy","volume":"145","author":"Sottile","year":"2019","journal-title":"Int J Cancer"},{"key":"2026041310015943800_bib47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41419-023-06240-x","article-title":"Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells","volume":"14","author":"Chrisochoidou","year":"2023","journal-title":"Cell Death Dis"},{"key":"2026041310015943800_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nmeth.4380","article-title":"Simultaneous epitope and transcriptome measurement in single cells","volume":"14","author":"Stoeckius","year":"2017","journal-title":"Nat Methods"},{"key":"2026041310015943800_bib49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-23-0017\/3484650\/cd-23-0017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-23-0017\/3491245\/cd-23-0017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/14\/11\/2262\/3509904\/cd-23-0017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/14\/11\/2262\/3509904\/cd-23-0017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:02:14Z","timestamp":1776088934000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/14\/11\/2262\/749213\/Single-Cell-View-of-Tumor-Microenvironment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,7,3]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-23-0017","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.32699772","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699784","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699742","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699760","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27433993","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27433981","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27434005","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699754","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27434011","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699766","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27434023","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699748","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699778","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27433996","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699763","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27434020","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27434014","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699769","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27434026","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699745","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32699739","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27433990","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27433999","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.27433987","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.14.585048","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.7520317","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]}}}